


NovAliX invests €5.3M to expand its DNA-Encoded Library platform

Advent France Biotechnology crée Gamut Therapeutics et finance son amorçage

Robocath bolsters Strategic Committee with appointment of Chantal Le Chat

QuantaMatrix debuts on KOSDAQ on Dec 9 as IPO prices at high end, raising USD 40.2M

Sebia enters into license agreement with Erasmus MC and Radboudumc to provide minimal residual disease test from serum samples of multiple myeloma patients

Amolyt Pharma lance une collaboration de recherche avec PeptiDream

Domain Therapeutics launches Phase 1-enabling studies on proprietary EP4 receptor antagonist program in cancer immunotherapy

Provepharm Life Solutions acquires Apollo Pharmaceuticals USA to continue growth in the United States
